Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurological condition related, in part, to the brain's chemistry and anatomy. ADHD manifests itself as a persistent pattern of inattention and/or hyperactivity/impulsivity that occurs more frequently and more severely than is typically observed in people at comparable levels of development.

ADHD begins in childhood and can persist into adulthood as well. While some children outgrow ADHD, about 60% continue to have symptoms into adulthood.

Approximately 7.8 percent of all school-age children, or about 4.4 million U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to U.S. Centers for Disease Control and Prevention (CDC). It is also estimated to affect 8.1 percent of adults, or approximately 9.1 million adults across the U.S based on retrospective survey of adults aged 18 to 44, projected to the full U.S. adult population.

ADHD Programs

SPN811:

• New indication for a product that was marketed in the US.
  

SPN812:

• New indication for a product that was marketed in the EU.
  
• In Phase II.